We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Open Orphan Plc | LSE:ORPH | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.00 | 9.50 | 10.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/1/2021 18:15 | BiondVax ‘exploring opportunities’ & recent increase in share price - could this involve Imutex, PrepBiopharm or ConserV Bioscience? Mr. Amir Reichman noted: "I am extremely excited and thrilled to assume the role of BiondVax's CEO. Thanks to the strong foundations built by Ron and his team, as well as the experience and ongoing support of our Board of Directors, BiondVax has tremendous potential to grow into a leading pharmaceutical company. Our mission at BiondVax is to create a healthier world by preventing and curing infectious diseases….We continue to believe there is a compelling need and demand for vaccines and therapeutics for infectious diseases, and we are currently exploring various potential paths forward including collaborations and other opportunities to build a new product pipeline that will help us achieve our mission.” 'The company is now pursuing opportunities in the infectious disease space, including exploring several alternatives for development of a pipeline of assets.' hxxp://www.biondvax. | trader_3 | |
22/1/2021 18:09 | The Bidstats confirmation of £46m contract award is also on the PR firm website home page, but this was announced in october? hxxps://novuscomms.c | kenwrong | |
22/1/2021 16:53 | If he did that then BIONDVAX could 10 bag !!!! | bobsworth | |
22/1/2021 16:50 | Pierre....I have contributed to ADVFN for 20 years and Mello give them an opportunity to meet investors and enjoy our physical events when we can run them. These are genuine events for investors to engage and benefit from. Nothing wrong with alerting shareholders if their company is presenting or to be analysed on the show. | davidosh | |
22/1/2021 16:31 | BiondVax up around 80% this week, with huge volume yesterday. Feels like the market thinks something is imminent. | 1gw | |
22/1/2021 16:00 | Sounds like the delivery people are paying even less than CF M5...perhaps he is a bit of a softee after all :-)) | marvelman | |
22/1/2021 15:50 | Steady as she goes then folks. Just a waiting game now. Dropped the camera off on set and they started filming at 1.30. Bloody generator company only want £60.00 to pick it up. I spent £30.00 on diesel!! Lesson learnt there. Still bloody learning them at 55. Have a good weekend all. You have to say everything seems to be slotting nicely into place here. The only thing wrong is the sp, but it will catch up for sure. | m5 | |
22/1/2021 13:38 | GregB.....You sound very negative. The BASH panel have made some very good calls over the last six months and it is always interesting to see how they value companies. This is nearly always the most popular session of the evening | davidosh | |
22/1/2021 13:31 | Thanks for the offer Davidosh but no matter what the anal ists say I will continue to hold and buy more when funds allow. | gregb | |
22/1/2021 13:05 | Just to let shareholders and prospective investors know that we will be featuring Open Orphan in the #MelloMonday show on Monday evening in the MelloBASH (Buy, Avoid, Sell or Hold)session with four leading analysts and investors assessing the current investment case for each of the four companies to be covered. The panel this week will also be looking at Ultimate Products Group and Twitter from a list of companies nominated. We also have guest speaker Lord John Lee who writes regularly in the FT and has a session looking at takeovers and how investors miss out. Additionally there are three companies doing presentations so a chance to see HeiQ who only listed three months ago and Tatton Asset Management plus a Game changer company that will be revealed on the night. Lots more sessions too and with 600 in the audience it will make for a great show with lots of Q&A and audience polls including one about Open Orphan so do not miss it. Tickets are still available and if you would like one at half price then enter the code MMTADVFN50 | davidosh | |
22/1/2021 12:29 | So much buying. No momentum on price. Anyone else surprised that no Institution is interested in taking over the sellers remaining stock ? | klosters65 | |
22/1/2021 10:50 | A good read on human challenge trails. | sh0wmethemoney | |
22/1/2021 10:36 | m5 - that's hilarious and the rain just made it worse. You are right. The things we do for our kids. Maybe ORPH will help us to do more in the coming months :-) | wassapper | |
22/1/2021 08:53 | I enjoyed reading M5 10901 & 10905. | 666james | |
22/1/2021 08:50 | RSP bid 24.87 v Ask 24.85 | sh0wmethemoney | |
22/1/2021 08:38 | It was announced on 20 October 2020. It is worth more than was explained by CF in his presso afterwards. £10m has already been paid. | slartybartfaster | |
22/1/2021 08:37 | Brilliant M5 | john henry | |
22/1/2021 08:34 | So the market has decided Rivaldo's find on the government contract should be price-moving even if ORPH hasn't RNS'd it yet? | 1gw | |
22/1/2021 08:24 | just got offered 24.6111p to sell | 666james | |
22/1/2021 08:20 | offer finally moved up | jeanesy | |
22/1/2021 08:19 | And 24.5 p to sell too | jeanesy | |
22/1/2021 08:14 | Jeansey its 24.5p to buy ive just added. | john henry |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions